← All companies
APYX
Apyx Medical Corporation
$4.18
+0.06 +1.46%
Key statistics
from XBRL data in SEC filingsMarket cap
$175M
Revenue (TTM)
$55.9M
Net income (TTM)
-$9.17M
EPS (TTM)
$-0.22
P/E ratio
—
Dividend yield
—
Free cash flow
-$9.12M
Cash
$31.1M
Total assets
$63.0M
Gross margin
63.2%
52-week range
$1.70 – $5.08
Recent SEC filings
40 most recentAnnual, quarterly & current reports
8-K
Other events
Jul 24, 2026
8-K
Entered a material agreement
Jun 17, 2026
8-K
Other events
May 21, 2026
8-K
Other events
May 14, 2026
8-K
Other events
May 11, 2026
10-Q
Quarter ended 2026-03-31
May 7, 2026
8-K
Results of operations (earnings release)
May 7, 2026
10-K
Fiscal year ended 2025-12-31
Mar 10, 2026
8-K
Results of operations (earnings release)
Mar 10, 2026
8-K
Results of operations (earnings release)
Jan 12, 2026
8-K
Amended charter or bylaws
Dec 12, 2025
8-K
Entered a material agreement; Other events
Nov 19, 2025
10-Q
Quarter ended 2025-09-30
Nov 6, 2025
8-K
Results of operations (earnings release)
Nov 6, 2025
8-K
Shareholder vote results
Aug 13, 2025
10-Q
Quarter ended 2025-06-30
Aug 7, 2025
8-K
Results of operations (earnings release)
Aug 7, 2025
8-K
Other events
May 13, 2025
10-Q
Quarter ended 2025-03-31
May 8, 2025
8-K
Results of operations (earnings release)
May 8, 2025
8-K
Other events
Apr 29, 2025
10-K
Fiscal year ended 2024-12-31
Mar 13, 2025
8-K
Results of operations (earnings release)
Mar 13, 2025
8-K
Director or officer change
Feb 6, 2025
8-K
Results of operations (earnings release)
Jan 13, 2025
8-K
Other events
Jan 6, 2025
10-Q
Quarter ended 2024-09-30
Nov 8, 2024
8-K
Entered a material agreement; Results of operations (earnings release); Took on a direct financial obligation; Unregistered sale of equity; Director or officer change; Other events
Nov 8, 2024
8-K
Shareholder vote results
Aug 12, 2024
10-Q
Quarter ended 2024-06-30
Aug 8, 2024
8-K
Results of operations (earnings release)
Aug 8, 2024
10-Q
Quarter ended 2024-03-31
May 9, 2024
8-K
Results of operations (earnings release)
May 9, 2024
8-K
Entered a material agreement; Director or officer change
May 9, 2024
10-K
Fiscal year ended 2023-12-31
Mar 21, 2024
8-K
Results of operations (earnings release)
Mar 21, 2024
8-K
Other events
Feb 21, 2024
8-K
Other events
Jan 22, 2024
8-K
Results of operations (earnings release)
Jan 8, 2024
8-K
Director or officer change; Regulation FD disclosure
Nov 28, 2023